FORZINITY

Launch

elamipretide hydrochloride

NDASUBCUTANEOUSSOLUTIONPriority Review
Approved
Sep 2025
Lifecycle
Launch
Competitive Pressure
0/100

Mechanism of Action

12.1 Mechanism of Action FORZINITY is a mitochondrial cardiolipin binder that localizes to the inner mitochondrial membrane and improves mitochondrial morphology and function. 12.2 Pharmacodynamics Effects on QTc Interval Cardiac electrophysiology Clinically significant QTc interval prolongation…

Loss of Exclusivity

LOE Date
Feb 28, 2034
97 months away
Patent Expiry
Feb 28, 2034
Exclusivity Expiry
Sep 19, 2030

Patent Records (5)

Patent #ExpiryTypeUse Code
7576061
Jan 20, 2027
SubstanceProduct
11083771
Feb 28, 2034
U-4277
11083772
Feb 28, 2034
U-4277
11771734
Feb 28, 2034
U-4277
12268724
Feb 28, 2034
U-4277